medinfoАктуальные проблемы теоретической и клинической медициныActual Problems of Theoretical and Clinical Medicine2790-12892790-1297Казахстанско-Российский медицинский университет10.24412/2790-1289-2025-1-93-106medinfo-638Research ArticleОБЗОР ЛИТЕРАТУРЫREVEWSОПЫТ СОЦИАЛЬНО-ЭКОНОМИЧЕСКИХ ПОСЛЕДСТВИЙ ДИАБЕТА В НЕКОТОРЫХ СТРАНАХ МИРАSOCIO-ECONOMIC IMPACTS OF DIABETES IN VARIOUS COUNTRIEShttps://orcid.org/0000-0001-8910-5658БеисоваА. А.BeisovaA. A.

Беисова Айнагуль Айдарбековна – PhD докторант кафедры политики и организации здравоохранения

Алматы

Ainagul Aidarbekovna Beisova – PhD student of the Department of Health Policy and Organization

Almaty

abeissova@yandex.ruТакамураН.TakamuraN.

Нобору Такамура – доктор медицинских наук, профессор кафедры глобального здравоохранения, медицины и социального обеспечения Института болезней атомных бомб Университета Нагасаки, заместитель директора Института радиоактивности окружающей среды, директор Университета Фукусимы

Нагасаки

Noboru Takamura –Doctor of Medical Sciences, Professor at the Department of Global Health, Medicine and Social Welfare at the Institute of Atomic Bomb Diseases at Nagasaki University, Deputy Director of the Institute of Environmental Radioactivity, Director of Fukushima University

Nagasaki

takamura@nagasaki-u.ac.jphttps://orcid.org/0000-0003-4105-4008КамхенВ. Б.KamkhenV. B.

Камхен Виталий Брониславович – доцент кафедры политики и организации здравоохранения Казахского национального университета имени Аль-Фараби, PhD по специальности «6D110200- Общественное здравоохранение», звание ассоциированного профессора

Алматы

Vitaliy Bronislavovich Kamkhen – Associate Professor of the Department of Health Policy and Organization of the Аl-Farabi Kazakh National University, PhD in the specialty «6D110200-Public Health»

Almaty

vitaliy.kamkhen@kaznu.eduhttps://orcid.org/0009-0003-5032-1670МукатаеваА. Ж.MukatayevaA. Zh.

Мукатаева Асылзада Жанболатовна – невролог, преподаватель кафедры политики и организации здравоохранения

Алматы

Asylzada Zhanbolatovna Mukatayeva – neurologist, lecturer at the Department of Health Policy and Organization

Almaty

asylzada.mukatayeva@gmail.comКазахский Национальный университет имени Аль–ФарабиКазахстан«Al-Farabi Kazakh National University» NJSCKazakhstanУниверситет НагасакиЯпонияNagasaki UniversityJapan2025080420250193106Copyright © Беисова А.А., Такамура Н., Камхен В.Б., Мукатаева А.Ж., 20252025Беисова А.А., Такамура Н., Камхен В.Б., Мукатаева А.Ж.Beisova A.A., Takamura N., Kamkhen V.B., Mukatayeva A.Z.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://kazrosmedjournal.krmu.edu.kz/jour/article/view/638

Экономическое бремя сахарного диабета особенно выражено в странах с низким и средним уровнем дохода, где пациенты часто вынуждены самостоятельно покрывать расходы на лечение. Анализ показывает, что затраты, связанные с диабетом, значительно различаются в зависимости от уровня дохода страны: в США эти расходы крайне высоки. Также подчёркивается различие в структуре расходов — в странах с низким доходом основная часть затрат приходится на медикаменты, в то время как в странах с высоким доходом значительные средства расходуются на лечение осложнений. Особое внимание уделяется экономическим последствиям таких осложнений, как сердечно-сосудистые заболевания, ретинопатия и ампутации конечностей.

Цель

Цель. Определить значимость раннего выявления и профилактических мер для снижения экономического бремени, связанного с сахарным диабетом.

Материалы и методы

Материалы и методы. Для подготовки данной статьи был проведён обзор литературы из баз данных PubMed, EMBASE, EconLit и IBSS. Для оценки мирового экономического бремени сахарного диабета, независимо от его типа, использовались эпидемиологические и экономические данные из 184 стран.

Выводы

Выводы. Результаты исследования показали, что экономическое бремя сахарного диабета неуклонно растёт и к 2035 году может превысить 1 триллион долларов США. Эта проблема особенно актуальна для стран с низким уровнем дохода, где 75% расходов на лечение ложатся на самих пациентов, что ограничивает доступ к медицинской помощи, приводит к поздней диагностике диабета, увеличению количества осложнений и росту финансовых издержек.

The economic burden of diabetes is particularly evident in low- and middle-income countries, where patients often have to cover healthcare expenses out of pocket. Analysis shows that diabetes-related costs vary significantly depending on a country's income level, with expenditures being extremely high in the United States. Attention is also drawn to differences in the structure of costs: in poorer countries, the main expenses are related to medications, whereas in wealthier countries, a significant portion of spending is allocated to treating complications. Special emphasis is placed on the economic consequences of diabetes complications, such as cardiovascular diseases, retinopathy, and amputations.

Objective

Objective. To highlight the importance of early detection and preventive measures in reducing the economic burden associated with diabetes.

Materials and Methods

Materials and Methods. This article is based on a literature review conducted using PubMed, EMBASE, EconLit, and IBSS databases. Epidemiological and economic data from 184 countries were used to assess the global economic burden of diabetes, regardless of its type.

Conclusion

Conclusion. The study results demonstrate that the economic burden of diabetes is steadily increasing and may exceed USD 1 trillion by 2035. This issue is particularly relevant in low-income countries, where 75% of treatment costs fall on patients themselves, limiting access to healthcare, leading to late diagnosis of diabetes, an increase in the number of complications, and a rise in financial costs.

сахарный диабетэкономическое бремяпрямые расходыкосвенные расходырасходы на лекарстваDiabetes mellituseconomic burdendirect costsindirect costsmedication costsReferencesBommer C., Sagalova V., Heesemann E., Manne-Goehler J., Atun R., Bärnighausen T., Davies J., Vollmer S. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030 // Diabetes Care. – 2018. – Vol. 41(5). – P.963-970. – DOI: 10.2337/dc17-1962.Bommer, C., Sagalova, V., Heesemann, E., Manne-Goehler, J., Atun, R., Bärnighausen, T., Davies, J., & Vollmer, S. (2018). Global economic burden of diabetes in adults: Projections from 2015 to 2030. Diabetes Care, 41(5), 963-970. DOI: https://doi.org/10.2337/dc17-1962Liu X., Zhang L., Chen W. Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data // Front Public Health. – 2023. – Vol. 11. – Article No. 1062903. – DOI: 10.3389/fpubh.2023.1062903.Liu, X., Zhang, L., & Chen, W. (2023). Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data. Frontiers in Public Health, 11, 1062903. DOI: https://doi.org/10.3389/fpubh.2023.1062903Bommer C., Heesemann E., Sagalova V., Manne-Goehler J., Atun R., Bärnighausen T., Vollmer S. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study // Lancet Diabetes Endocrinol. – 2017. – Vol. 5(6). – P.423-430. – DOI: 10.1016/S2213-8587(17)30097-9.Bommer, C., Heesemann, E., Sagalova, V., Manne-Goehler, J., Atun, R., Bärnighausen, T., & Vollmer, S. (2017). The global economic burden of diabetes in adults aged 20-79 years: A cost-ofillness study. The Lancet Diabetes & Endocrinology, 5(6), 423-430. DOI: https://doi.org/10.1016/S2213-8587(17)30097-9Seuring T., Archangelidi O., Suhrcke M. The Economic Costs of Type 2 Diabetes: A Global Systematic Review // Pharmacoeconomics. – 2015. – Vol. 33(8). – P. 811-831. – DOI: 10.1007/s40273-015-0268-9.Seuring, T., Archangelidi, O., & Suhrcke, M. (2015). The economic costs of type 2 diabetes: A global systematic review. Pharmacoeconomics, 33(8), 811-831. DOI: https://doi.org/10.1007/s40273-015-0268-9Kansra P., Oberoi S. Cost of diabetes and its complications: results from a STEPS survey in Punjab, India // Glob Health Res Policy. – 2023. – Vol. 8(1). – P. 11. – DOI: 10.1186/s41256-023-00293-3.Kansra, P., & Oberoi, S. (2023). Cost of diabetes and its complications: Results from a STEPS survey in Punjab, India. Global Health Research and Policy, 8(1), 11. DOI: https://doi.org/10.1186/s41256-023-00293-3Sarker A. R., Khanam M. Socio-economic inequalities in diabetes and prediabetes among Bangladeshi adults // Diabetol Int. – 2021. – Vol. 13(2). – P. 421-435. – DOI: 10.1007/s13340-021-00556-9.Sarker, A. R., & Khanam, M. (2021). Socioeconomic inequalities in diabetes and prediabetes among Bangladeshi adults. Diabetology International, 13(2), 421-435. DOI: https://doi.org/10.1007/s13340-021-00556-9Walker I. F., Garbe F., Wright J., Newell I., Athiraman N., Khan N., Elsey H. The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia: A Systematic Review // Value Health Reg Issues. – 2018. – Vol. 15. – P. 12-26. – DOI: 10.1016/j.vhri.2017.05.003.Walker, I. F., Garbe, F., Wright, J., Newell, I., Athiraman, N., Khan, N., & Elsey, H. (2018). The economic costs of cardiovascular disease, diabetes mellitus, and associated complications in South Asia: A systematic review. Value in Health Regional Issues, 15, 12-26. DOI: https://doi.org/10.1016/j.vhri.2017.05.003Shariful Islam S. M., Lechner A., Ferrari U., Laxy M., Seissler J., Brown J., Niessen L. W., Holle R. Healthcare use and expenditure for diabetes in Bangladesh // BMJ Glob Health. – 2017. – Vol. 2(1). – Article No. 000033. – DOI: 10.1136/bmjgh-2016-000033.Shariful Islam, S. M., Lechner, A., Ferrari, U., Laxy, M., Seissler, J., Brown, J., Niessen, L. W., & Holle, R. (2017). Healthcare use and expenditure for diabetes in Bangladesh. BMJ Global Health, 2(1), 000033. DOI: https://doi.org/10.1136/bmjgh-2016-000033Hossain Z., Khanam M., Razzaque Sarker A. Outof-pocket expenditure among patients with diabetes in Bangladesh: A nation-wide population-based study // Health Policy Open. – 2023. – Vol. 5. – P. 100102. – DOI: 10.1016/j.hpopen.2023.100102.Hossain, Z., Khanam, M., & Razzaque Sarker, A. (2023). Out-of-pocket expenditure among patients with diabetes in Bangladesh: A nation-wide population-based study. Health Policy Open, 5, 100102. DOI: https://doi.org/10.1016/j.hpopen.2023.100102Afroz A., Alam K., Ali L., Karim A., Alramadan M. J., Habib S. H., Magliano D. J., Billah B. Type 2 diabetes mellitus in Bangladesh: a prevalencebased cost-of-illness study // BMC Health Serv Res. – 2019. – Vol. 19(1). – P. 601. – DOI: 10.1186/s12913-019-4440-3.Afroz, A., Alam, K., Ali, L., Karim, A., Alramadan, M. J., Habib, S. H., Magliano, D. J., & Billah, B. (2019). Type 2 diabetes mellitus in Bangladesh: A prevalence-based cost-of-illness study. BMC Health Services Research, 19(1), 601. DOI: https://doi.org/10.1186/s12913-019-4440-3Gillani A. H., Aziz M. M., Masood I., Saqib A., Yang C., Chang J., Mohamed Ibrahim M. I., Fang Y. Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: a multicenter study in Punjab, Pakistan // Expert Rev Pharmacoecon Outcomes Res. – 2018. – Vol. 18(6). – P. 647-653. – DOI: 10.1080/14737167.2018.1503953.Gillani, A. H., Aziz, M. M., Masood, I., Saqib, A., Yang, C., Chang, J., Mohamed Ibrahim, M. I., & Fang, Y. (2018). Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: A multicenter study in Punjab, Pakistan. Expert Review of Pharmacoeconomics & Outcomes Research, 18(6), 647-653. DOI: https://doi.org/10.1080/14737167.2018.1503953Rosa M. Q. M., Rosa R.D.S, Correia M. G., Araujo D. V., Bahia L. R., Toscano C. M. Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil // Int J Environ Res Public Health. – 2018. – Vol. 15(2). – P. 294. – DOI: 10.3390/ijerph15020294.Rosa, M. Q. M., Rosa, R. D. S., Correia, M. G., Araujo, D. V., Bahia, L. R., & Toscano, C. M. (2018). Disease and economic burden of hospitalizations attributable to diabetes mellitus and its complications: A nationwide study in Brazil. International Journal of Environmental Research and Public Health, 15(2), 294. DOI: https://doi.org/10.3390/ijerph15020294Butt M. D., Ong S. C., Wahab M. U., Rasool M. F., Saleem F., Hashmi A., Sajjad A., Chaudhry F. A., Babar Z. U. Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country // Int J Environ Res Public Health. – 2022. – Vol. 19(19). – P. 12611. – DOI: 10.3390/ijerph191912611.Butt, M. D., Ong, S. C., Wahab, M. U., Rasool, M. F., Saleem, F., Hashmi, A., Sajjad, A., Chaudhry, F. A., & Babar, Z. U. (2022). Cost of illness analysis of type 2 diabetes mellitus: The findings from a lower-middle-income country. International Journal of Environmental Research and Public Health, 19(19), 12611. DOI: https://doi.org/10.3390/ijerph191912611Alowayesh M. S., Aljunid S. M., Al-Adsani A., Alessa T., Alattar A., Alroudhan D. Utilization and cost of drugs for diabetes and its comorbidities and complications in Kuwait // PLoS One. – 2022. – Vol. 17(6). – Article No. 0268495. – DOI: 10.1371/journal.pone.0268495.Alowayesh, M. S., Aljunid, S. M., Al-Adsani, A., Alessa, T., Alattar, A., & Alroudhan, D. (2022). Utilization and cost of drugs for diabetes and its comorbidities and complications in Kuwait. PLOS ONE, 17(6), 0268495. DOI: https://doi.org/10.1371/journal.pone.0268495Namazi N., Moghaddam S. S., Esmaeili S., Peimani M., Tehrani Y. S., Bandarian F., Shobeiri P., Nasli-Esfahani E., Malekpour M. R., Rezaei N., Rezaei N., Arjmand B., Larijani B., Farzadfar F. Burden of type 2 diabetes mellitus and its risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease study 2019 // BMC Public Health. – 2024. – Vol. 24(1). – P. 98. – DOI: 10.1186/s12889-023-16540-8.Namazi, N., Moghaddam, S. S., Esmaeili, S., Peimani, M., Tehrani, Y. S., Bandarian, F., Shobeiri, P., Nasli-Esfahani, E., Malekpour, M. R., Rezaei, N., Arjmand, B., Larijani, B., & Farzadfar, F. (2024). Burden of type 2 diabetes mellitus and its risk factors in North Africa and the Middle East, 1990-2019: Findings from the Global Burden of Disease study 2019. BMC Public Health, 24(1), 98. DOI: https://doi.org/10.1186/s12889-023-16540-8Oh S. H., Ku H., Park K. S. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data // BMC Public Health. – 2021. – Vol. 21(1). – P. 548. – DOI: 10.1186/s12889-021-10450-3.Oh, S. H., Ku, H., & Park, K. S. (2021). Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: A population-based study using administrative data. BMC Public Health, 21(1), 548. DOI: https://doi.org/10.1186/s12889-021-10450-3Afroz A., Alramadan M. J., Hossain M. N., Romero L., Alam K., Magliano D. J., Billah B. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review // BMC Health Serv Res. – 2018. – Vol. 18(1). – P. 972. – DOI: 10.1186/s12913-018-3772-8.Afroz, A., Alramadan, M. J., Hossain, M. N., Romero, L., Alam, K., Magliano, D. J., & Billah, B. (2018). Cost-of-illness of type 2 diabetes mellitus in low and lower-middle-income countries: A systematic review. BMC Health Services Research, 18(1), 972. DOI: https://doi.org/10.1186/s12913-018-3772-8American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017 // Diabetes Care. – 2018. – Vol. 41(5). – P. 917-928. – DOI: 10.2337/dci18-0007.American Diabetes Association. (2018). Economic costs of diabetes in the U.S. in 2017. Diabetes Care, 41(5), 917-928. DOI: https://doi.org/10.2337/dci18-0007Singh K., Narayan K. M. V., Eggleston K. Economic Impact of Diabetes in South Asia: the Magnitude of the Problem // Curr Diab Rep. – 2019. – Vol. 19(6). – P. 34. – DOI: 10.1007/s11892-019-1146-1.Singh, K., Narayan, K. M. V., & Eggleston, K. (2019). Economic impact of diabetes in South Asia: The magnitude of the problem. Current Diabetes Reports, 19(6), 34. DOI: https://doi.org/10.1007/s11892-019-1146-1Kaur G., Chauhan A. S., Prinja S., Teerawattananon Y., Muniyandi M., Rastogi A., Jyani G., Nagarajan K., Lakshmi P., Gupta A., Selvam J. M., Bhansali A., Jain S. Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study // Lancet Public Health. – 2022. – Vol. 7(1). – P. 65-73. – DOI: 10.1016/S2468-2667(21)00199-7.Kaur, G., Chauhan, A. S., Prinja, S., Teerawattananon, Y., Muniyandi, M., Rastogi, A., Jyani, G., Nagarajan, K., Lakshmi, P., Gupta, A., Selvam, J. M., Bhansali, A., & Jain, S. (2022). Cost-effectiveness of population-based screening for diabetes and hypertension in India: An economic modelling study. The Lancet Public Health, 7(1), 65-73. DOI: https://doi.org/10.1016/S2468-2667(21)00199-7Bansode B., Jungari D. S. Economic burden of diabetic patients in India: A review // Diabetes Metab Syndr. – 2019. – Vol. 13(4). – P. 2469-2472. – DOI: 10.1016/j.dsx.2019.06.020.Bansode, B., & Jungari, D. S. (2019). Economic burden of diabetic patients in India: A review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(4), 2469-2472. DOI: https://doi.org/10.1016/j.dsx.2019.06.020Mutyambizi C., Pavlova M., Hongoro C., Booysen F., Groot W. Incidence, socio-economic inequalities and determinants of catastrophic health expenditure and impoverishment for diabetes care in South Africa: a study at two public hospitals in Tshwane // Int J Equity Health. – 2019. – Vol. 18(1). – P. 73. – DOI: 10.1186/s12939-019-0977-3.Mutyambizi, C., Pavlova, M., Hongoro, C., Booysen, F., & Groot, W. (2019). Incidence, socioeconomic inequalities and determinants of catastrophic health expenditure and impoverishment for diabetes care in South Africa: A study at two public hospitals in Tshwane. International Journal for Equity in Health, 18(1), 73. DOI: https://doi.org/10.1186/s12939-019-0977-3Gwatidzo S. D., Stewart Williams J. Diabetes mellitus medication use and catastrophic healthcare expenditure among adults aged 50+ years in China and India: results from the WHO study on global AGEing and adult health (SAGE) // BMC Geriatr. – 2017. – Vol. 17(1). – P. 14. – DOI: 10.1186/s12877-016-0408-x.Gwatidzo, S. D., & Stewart Williams, J. (2017). Diabetes mellitus medication use and catastrophic healthcare expenditure among adults aged 50+ years in China and India: Results from the WHO study on global AGEing and adult health (SAGE). BMC Geriatrics, 17(1), 14. DOI: https://doi.org/10.1186/s12877-016-0408-xFu Y., Chen M., Si L. Multimorbidity and catastrophic health expenditure among patients with diabetes in China: a nationwide population-based study // BMJ Glob Health. – 2022. – Vol. 7(2). – Article No. 007714. – DOI: 10.1136/bm-jgh-2021-007714.Fu, Y., Chen, M., & Si, L. (2022). Multimorbidity and catastrophic health expenditure among patients with diabetes in China: A nationwide population-based study. BMJ Global Health, 7(2), 007714. DOI: https://doi.org/10.1136/bmjgh-2021-007714Ansari-Moghaddam A., Setoodehzadeh F., Khammarnia M., Adineh H. A. Economic cost of diabetes in the Eastern Mediterranean region countries: A meta-analysis // Diabetes Metab Syndr. – 2020. – Vol.14(5). – P. 1101-1108. – DOI: 10.1016/j.dsx.2020.06.044.Ansari-Moghaddam, A., Setoodehzadeh, F., Khammarnia, M., & Adineh, H. A. (2020). Economic cost of diabetes in the Eastern Mediterranean region countries: A meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 1101-1108. DOI: https://doi.org/10.1016/j.dsx.2020.06.044Piroozi B., Mohamadi-Bolbanabad A., Moradi G., Safari H., Ghafoori S., Zarezade Y., Bidarpour F., Rezaei S. Incidence and Intensity of Catastrophic Health-care Expenditure for Type 2 Diabetes Mellitus Care in Iran: Determinants and Inequality // Diabetes Metab Syndr Obes. – 2020. – Vol. 13. – P. 2865-2876. – DOI: 10.2147/DMSO.S263571.Piroozi, B., Mohamadi-Bolbanabad, A., Moradi, G., Safari, H., Ghafoori, S., Zarezade, Y., Bidarpour, F., & Rezaei, S. (2020). Incidence and intensity of catastrophic healthcare expenditure for type 2 diabetes mellitus care in Iran: Determinants and inequality. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 2865-2876. DOI: https://doi.org/10.2147/DMSO.S263571Schofield D., Shrestha R. N., Cunich M. M., Passey M. E., Veerman L., Tanton R., Kelly S. J. The costs of diabetes among Australians aged 45-64 years from 2015 to 2030: projections of lost productive life years (PLYs), lost personal income, lost taxation revenue, extra welfare payments and lost gross domestic product from Health&WealthMOD2030 // BMJ Open. – 2017. – Vol. 7(1). – Article No. 013158. – DOI: 10.1136/bmjopen-2016-013158.Schofield, D., Shrestha, R. N., Cunich, M. M., Passey, M. E., Veerman, L., Tanton, R., & Kelly, S. J. (2017). The costs of diabetes among Australians aged 45-64 years from 2015 to 2030: Projections of lost productive life years (PLYs), lost personal income, lost taxation revenue, extra welfare payments and lost gross domestic product from Health&WealthMOD2030. BMJ Open, 7(1), e013158. DOI: https://doi.org/10.1136/bmjopen-2016-013158Barcelo A., Arredondo A., Gordillo-Tobar A., Segovia J., Qiang A. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers // J Glob Health. – 2017. – Vol. 7(2). – Article No. 020410. – DOI: 10.7189/jogh.07.020410.Barcelo, A., Arredondo, A., Gordillo-Tobar, A., Segovia, J., & Qiang, A. (2017). The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers. Journal of Global Health, 7(2), 020410. DOI: https://doi.org/10.7189/jogh.07.020410Dahal P. K., Rawal L., Ademi Z., Mahumud R. A., Paudel G., Vandelanotte C. Estimating the Health Care Expenditure to Manage and Care for Type 2 Diabetes in Nepal: A Patient Perspective // MDM Policy Pract. – 2023. – Vol. 8(2). – Article No.23814683231216938. – DOI: 10.1177/23814683231216938.Dahal, P. K., Rawal, L., Ademi, Z., Mahumud, R. A., Paudel, G., & Vandelanotte, C. (2023). Estimating the healthcare expenditure to manage and care for type 2 diabetes in Nepal: A patient perspective. MDM Policy & Practice, 8(2), 23814683231216938. DOI: https://doi.org/10.1177/23814683231216938Foos V., Wang K., McEwan P., Zhang Y., Xin P., Jiang X., Qu S., Xiong T., De Moor R., Ramos M., Lamotte M., Ji L. Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach // Value Health Reg Issues. – 2019. – Vol. 18. – P. 36-46. – DOI: 10.1016/j.vhri.2018.08.006.Foos, V., Wang, K., McEwan, P., Zhang, Y., Xin, P., Jiang, X., Qu, S., Xiong, T., De Moor, R., Ramos, M., Lamotte, M., & Ji, L. (2019). Assessing the burden of type 2 diabetes in China considering the current status-quo management and implications of improved management using a modeling approach. Value in Health Regional Issues, 18, 36-46. DOI: https://doi.org/10.1016/j.vhri.2018.08.006Liang D., Zhu W., Huang J., Dong Y. A health economic analysis of an integrated diabetes care program in China: based on real-world evidence // Front Public Health. – 2023. – Vol. 11. – Article No. 1211671. – DOI: 10.3389/fpubh.2023.1211671.Liang, D., Zhu, W., Huang, J., & Dong, Y. (2023). A health economic analysis of an integrated diabetes care program in China: Based on real-world evidence. Frontiers in Public Health, 11, 1211671. DOI: https://doi.org/10.3389/fpubh.2023.1211671Erzse A., Stacey N., Chola L., Tugendhaft A., Freeman M., Hofman K. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study // Glob Health Action. – 2019. – Vol. 12(1). – Article No.1636611. – DOI: 10.1080/16549716.2019.1636611.Erzse, A., Stacey, N., Chola, L., Tugendhaft, A., Freeman, M., & Hofman, K. (2019). The direct medical cost of type 2 diabetes mellitus in South Africa: A cost of illness study. Global Health Action, 12(1), 1636611. DOI: https://doi.org/10.1080/16549716.2019.1636611Mapa-Tassou C., Katte J. C., Mba Maadjhou C., Mbanya J. C. Economic Impact of Diabetes in Africa // Curr Diab Rep. – 2019. – Vol. 19(2). – P. 5. – DOI: 10.1007/s11892-019-1124-7.Mapa-Tassou, C., Katte, J. C., Mba Maadjhou, C., & Mbanya, J. C. (2019). Economic impact of diabetes in Africa. Current Diabetes Reports, 19(2), 5. DOI: https://doi.org/10.1007/s11892-019-1124-7Peters M. L., Huisman E. L., Schoonen M., Wolffenbuttel B. H. R. The current total economic burden of diabetes mellitus in the Netherlands // Neth J Med. – 2017. – Vol. 75(7). – P. 281-297Peters, M. L., Huisman, E. L., Schoonen, M., & Wolffenbuttel, B. H. R. (2017). The current total economic burden of diabetes mellitus in the Netherlands. Netherlands Journal of Medicine, 75(7), 281-297.Andersson E., Persson S., Hallén N., Ericsson Å., Thielke D., Lindgren P., Steen Carlsson K., Jendle J. Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden // Diabetologia. – 2020. – Vol. 63(12). – P. 2582-2594. – DOI: 10.1007/s00125-020-05277-3.Andersson, E., Persson, S., Hallén, N., Ericsson, Å., Thielke, D., Lindgren, P., Steen Carlsson, K., & Jendle, J. (2020). Costs of diabetes complications: Hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden. Diabetologia, 63(12), 2582-2594. DOI: https://doi.org/10.1007/s00125-020-05277-3

The authors declare that there are no conflicts of interest present.